Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2 ,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylm ethy]-4-fluor-benzonitrile and methods of use therefor

Details for Australian Patent Application No. 2007325107 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Kelly, Ron C.; Koztecki, Lien H.

Agent Griffith Hack

Pub. Number AU-A-2007325107

PCT Pub. Number WO2008/067465

Priority 60/867,764 29.11.06 US

Filing date 29 November 2007

Wipo publication date 5 June 2008

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/067465 Priority application(s): WO2008/067465

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007325113-Reverse link traffic power control for LBC FDD

2007325096-System and method for digital signal processing